Harvard Radiation Oncology Program, Boston, Massachusetts.
Department of Statistics, University of Connecticut, Storrs, Connecticut.
Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):756-64. doi: 10.1016/j.ijrobp.2014.03.024. Epub 2014 May 3.
Surgery and radiation therapy represent the only curative options for many patients with solid malignancies. However, despite the recommendations of their physicians, some patients refuse these therapies. This study characterized factors associated with refusal of surgical or radiation therapy as well as the impact of refusal of recommended therapy on patients with localized malignancies.
We used the Surveillance, Epidemiology, and End Results program to identify a population-based sample of 925,127 patients who had diagnoses of 1 of 8 common malignancies for which surgery and/or radiation are believed to confer a survival benefit between 1995 and 2008. Refusal of oncologic therapy, as documented in the SEER database, was the primary outcome measure. Multivariable logistic regression was used to investigate factors associated with refusal. The impact of refusal of therapy on cancer-specific mortality was assessed with Fine and Gray's competing risks regression.
In total, 2441 of 692,938 patients (0.4%) refused surgery, and 2113 of 232,189 patients (0.9%) refused radiation, despite the recommendations of their physicians. On multivariable analysis, advancing age, decreasing annual income, nonwhite race, and unmarried status were associated with refusal of surgery, whereas advancing age, decreasing annual income, Asian American race, and unmarried status were associated with refusal of radiation (P<.001 in all cases). Refusal of surgery and radiation were associated with increased estimates of cancer-specific mortality for all malignancies evaluated (hazard ratio [HR], 2.80, 95% confidence interval [CI], 2.59-3.03; P<.001 and HR 1.97 [95% CI, 1.78-2.18]; P<.001, respectively).
Nonwhite, less affluent, and unmarried patients are more likely to refuse curative surgical and/or radiation-based oncologic therapy, raising concern that socioeconomic factors may drive some patients to forego potentially life-saving care.
手术和放疗是许多实体恶性肿瘤患者唯一的治愈选择。然而,尽管医生建议,一些患者还是拒绝这些治疗方法。本研究描述了与拒绝手术或放疗相关的因素,以及拒绝推荐治疗对局部恶性肿瘤患者的影响。
我们使用监测、流行病学和最终结果(SEER)数据库,确定了 1995 年至 2008 年间被诊断为 8 种常见恶性肿瘤之一的人群样本,这些肿瘤被认为手术和/或放疗可带来生存获益。SEER 数据库中记录的拒绝肿瘤治疗被作为主要观察终点。多变量逻辑回归用于调查与拒绝相关的因素。采用 Fine-Gray 竞争风险回归评估拒绝治疗对癌症特异性死亡率的影响。
在 692938 例接受手术治疗的患者中,有 2441 例(0.4%)拒绝手术,在 232189 例接受放疗的患者中,有 2113 例(0.9%)拒绝放疗,尽管医生建议他们接受治疗。多变量分析显示,年龄增长、年收入减少、非白种人种族和未婚状态与手术拒绝相关,而年龄增长、年收入减少、亚裔美国人种族和未婚状态与放疗拒绝相关(所有情况下 P<.001)。所有评估的恶性肿瘤中,拒绝手术和放疗与癌症特异性死亡率的估计值增加相关(危险比[HR],2.80,95%置信区间[CI],2.59-3.03;P<.001 和 HR 1.97 [95% CI,1.78-2.18];P<.001)。
非白种人、收入较低和未婚的患者更有可能拒绝根治性手术和/或放疗,这引发了对社会经济因素可能促使一些患者放弃潜在救生治疗的担忧。